Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Neuroblastoma and its Target Therapies: A Medicinal Chemistry Review

10 Feb 2024

Abstract excerpt

Neuroblastoma (NB) is a childhood malignant tumour belonging to a group of embryonic tumours originating from progenitor cells of the sympathoadrenal lineage. The heterogeneity of NB is reflected in the survival rates of those with low and intermediate risk diseases who have survival rates ranging from 85 to 90 %. However, for those identified with high-risk Stage 4 NB, the treatment options are much more...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cancer therapeutics and mechanisms
Share to Neuroblastoma Research and Treatments
Share to Protein Degradation and Inhibitors

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 38340043
DOI: 10.1002/cmdc.202300535

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Neuroblastoma and its Target Therapies: A Medicinal Chemistry ReviewPMID 38340043Read ↗

Neuroblastoma treatment in the post-genomic eraSemantic proximity Read ↗

Investigational drugs in phase II clinical trials for the treatment of neuroblastomaSemantic proximity Read ↗

Neuroblastoma: An Updated Review on Biology and TreatmentSemantic proximity Read ↗

Neuroblastoma: Molecular Pathogenesis and TherapySemantic proximity Read ↗

Targeting Pathways in Neuroblastoma: Advances in Treatment Strategies and Clinical OutcomesSemantic proximity Read ↗

Progress towards personalized therapeutics: biologic- and risk-directed therapy for neuroblastomaSemantic proximity Read ↗

Therapeutic targets for neuroblastomas.Semantic proximity Read ↗

Neuroblastoma: a clinical challenge and biologic puzzleSemantic proximity Read ↗

Molecular mechanisms and therapeutic targets in neuroblastomaSemantic proximity Read ↗

Neuroblastoma: biology, prognosis, and treatment.Semantic proximity Read ↗

Neuroblastoma: paradigm for precision medicine.Semantic proximity Read ↗

Cell death-based treatment of neuroblastomaSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.